Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice

Microbial Pathogenesis

Volumn 23, Issue 3, 1997, Pages 127-137

  Wu, Hong Yin ^a   Virolainen, Anni ^a   Mathews, Bonnie ^a   King, Janice ^a   Russell, Michael W ^a   Briles, David E ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Colonization; Mice; Nasopharyngeal carriage; Streptococcus pneumoniae

Indexed keywords

CHOLERA TOXIN B SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; IMMUNIZATION; MOUSE; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 0031239880     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1997.0142     Document Type: Article

References (47)

1. Anonymous. Centers for Disease Control HIV/AIDS Surveillance Report 1991; August: 1, 18.
2. Fraser DW. What are our bacterial disease problems. New York. Bacterial Vaccines. 1982;xix-xxiv.
3. Schwartz, B, Gove, S, Lob-Lovit, J, Kirkwood, BR, Potential interactions for the prevention of childhood pneumonia in developing countries: etiology of acute lower respiratory infections among young children in developing countries, Ped Infect Dis.
4. Farley JJ, King JC, Nair P, Hines SE, Tressler RL, Vink PE. Invasive pneumococcal disease among infected and uninfected children of mothers with immunodeficiency virus infection. J Pediatr. 124:1994;853-858.
5. Wong W-Y, Overturf GE, Powars DR. Infection caused byStreptococcus pneumoniae. Clin Infect Dis. 14:1992;1124-1136.
6. Hofmann J, Cetron MS, Farley MM, Baughman W, Facklam RR, Elliott JA, Deaver BA, Breiman RF. Prevalence of drug-resistantStreptococcus pneumoniae. N Engl J Med. 333:1995;481-486.
7. Munoz R, Musser JM, Crain M, Briles DE, Marton A, Parkinson AJ, Sorensen U, Tomasz A. Geographic distribution of penicillin-resistant clones ofStreptococcus pneumoniae. Clin Infect Dis. 15:1992;112-118.
8. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 3:1990;171-196.
9. Gray BM, Converse GM, Dillon HC. Epidemiologic studies ofStreptococcus pneumoniae. J Infect Dis. 142:1980;923-933.
10. Gray BM, Converse GM, Huhta N, Johnston RB, Pichichero ME, Schiffman G, Dillon HC. Antibody response to pneumococcal carriage. J Infect Dis. 142:1978;312-318.
11. Hendley JO, Sande MA, Stewart PM, Gwaltney J. Spread ofStreptococcus pneumoniae. J Infect Dis. 132:1975;55-61.
12. Smillie WG, Warnock GH, White HJ. A study of a type I pneumococcus epidemic at state hospital at Worchester Massachusetts. Am J Pub Health. 28:1938;293-302.
13. Smillie WG. A study of an outbreak of type II pneumococcal pneumonia in the Veterans Administration Hospital at Bedford, Massachusetts. Am J Hyg. 24:1936;522-535.
14. Gratten M, Naraqi S, Hansman D. High prevalence of penicillin-insensitive penumococci in Port Moresby, Papua New Guinea. Lancet. ii:1980;192-195.
15. DeMaria TF, McGhee RB, Lim DJ. Rheumatoid factor in otitis media with effusion. Arch Otolaryngol. 110:1984;279-280.
16. Bolan G, Broome CV, Facklam RR, Plikaytis BD, Fraser WD, Schlech WFI. Pneumococcal vaccine efficacy in selected populations in the Unites States. Ann Intern Med. 104:1986;1-6.
17. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemmens JD. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 325:1991;1453-1460.
18. Jernigan DB, Cetron MS, Breiman RF. Defining the public health impact of drug resistantStreptococcus pneumoniae: MMWR. 45:1996;1-20.
19. Cowan MJ, Ammann AJ, Wara DW, Howie VM, Schultz L, Doyle N, Kaplan M. Pneumococcal polysaccharide immunization in infants and children. Pediatrics. 62:1978;721-727.
20. Gotschlich EC, Goldschneider I, Lepow ML, Gold R. The immune response to bacterial polysaccharides in man. In: Haber E, Krause RM eds. Antibodies in human diagnosis and therapy. New York: Raven. 1977;391-402.
21. Takala AK, Eskola J, Leinonen M, Käythy H, Nissinen A, Pekkanen E, Makela PH. Reduction of oropharyngeal carriage ofHaemophilus influenzae. J Infect Dis. 164:1991;982-986.
22. Barbour ML, Mayon-White RT, Crook DW, Coles C, Moxon ER. The influence ofHaemophilus influenzae. ICAAC Abstracts. 33:1993;175.
23. MacLeod CM, Hodges RG, Heidelberger M, Bernhard WG. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med. 82:1945;445-465.
24. Douglas RM, Hansman D, Miles HB, Paton JC. Pneumococcal carriage and type-specific antibody. Failure of a 14-valent vaccine to reduce carriage in healthy children. Am J Dis Children. 140:1986;1183-1185.
25. Douglas RM, Miles HB. Vaccination againstStreptococcus pneumoniae. J Infect Dis. 149:1984;861-869.
26. Dagan R, Muallem R, Yagupsky P. Reduction of nasopharyngeal carriage of penicillin resistant pneumococci (PenRPnc) by pneumococcal-OMPC conjugate vaccine (Pnc-7-OMPC) during second year of life. ICAAC Abstract. 1995:1995;158.
27. Leach A, Cessay SJ, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet. 348:1996;271-272.
28. Weiser NJ, Austrian R, Sreenivasan PK, Masure HR. Phase variation in pneumococcal opacity: Relationship between colonial morphology and nasopharyngeal colonization. Infect Immun. 62:1994;2582-2589.
29. Weiser JN, Markiewicz A, Tuomanen EI, Wani JH. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization byStreptococcus pneumoniae. Infect Immun. 64:1996;2240-2245.
30. Amsbaugh DF, Hansen CT, Prescott B, Stashak PW, Barthold DR, Baker PJ. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med. 136:1972;931-949.
31. Briles DE, Nahm M, Schroer K, Davie J, Baker P, Kearney J, Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3Streptococcus pneumoniae. J Exp Med. 153:1981;694-705.
32. Wallick S, Claflin JL, Briles DE. Resistance toStreptococcus pneumoniae. J Immunol. 130:1983;2871-2875.
33. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. A strong association between capsular type and mouse virulence among human isolates ofStreptococcus pneumoniae. Infect Immun. 60:1992;111-116.
34. Briles DE, Forman C, Crain M. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates ofStreptococcus pneumoniae. Infect Immun. 60:1992;1957-1962.
35. Wu H-Y, Russell MW. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun. 61:1993;314-322.
36. Briles DE, Horowitz J, McDaniel LS, Benjamin WH, Claflin JL, Booker CL, Scott G, Forman C. Genetic control of susceptibility to pneumococcal infection. Curr Top Microbiol Immunol. 124:1986;103-120.
37. Benton KA, Paton JC, Briles D. Differences in virulence for mice amongStreptococcus pneumoniae. Infect Immun. 65:1997;1237-1244.
38. Aaberge IS, Eng J, Lermark G, Løvik M. Virulence ofStreptococcus pneumoniae. Microb Pathogen. 18:1995;141-152.
39. Russell MW, Wu H-Y. Distribution, persistence and recall of serum and salivary antibody response to peroral immunizations with protein antigen I/II ofStreptococcus mutans. Infect Immun. 59:1991;4061-4070.
40. Fallon MT, Reinhard MK, Gray BM, Davis TW, Lindsey JR. InapparentStreptococcus pneumoniae. Lab Anim Science. 38:1988;129-132.
41. Webster LT, Clow AD. Intranasal virulence of pneumococci for mice. J Exp Med. 58:1933;465-483.
42. Fallon MT, Benjamin WH, Schoeb TR, Briles DE. Mouse hepatitis virus strain UAB infection enhances resistance toSalmonella typhimurium. Infect Immun. 59:1991;852-856.
43. Giebink GS, Berzins IK, Schiffman G, Quie PQ. Experimental otitis media following nasal colonization with type 7FStreptococcus pneumoniae. J Infect Dis. 140:1979;716-723.
44. Briles DE, Tart RC, Wu H-Y, Ralph BA, Russell MW, McDaniel LS. Systemic and mucosal protective immunity to pneumococcal surface protein A. N Y Acad Sci. 797:1996;118-126.
45. Benton KA, Everson MP, Briles DE. A pneumolysin-negative mutant ofStreptococcus pneumoniae. Infect Immun. 63:1995;448-455.
46. Converse GM, Dillon HC. Epidemiological studies ofStreptococcus pneumoniae. J Clin Micro. 5:1977;293-296.
47. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill. 2:1988.